Intervention 1: Intervention group1: Ranolazine 500 mg ER Tablet , produced by Zist arvand Pharmed. is the test product. In each period, 12 of 24 subjects will be given single oral dose of this produc
Sponsors
Zist Arvand Pharme Ltd.
Conditions
Angina pectoris.
Angina pectoris
Phase 1
Comparative in vivo evaluation of 2 Ranolazine 1000 mg ER Tablet and Ranexa® 1000 mg ER Tablet formulations.
RecruitingIRCT20180620040164N50
Start: 2023-11-11Target: 24Updated: 2023-11-13
Comparative in vivo evaluation of 2 Ranolazine 500mg ER Tablet and Ranexa® 500 mg ER Tablet formulations.
RecruitingIRCT20180620040164N77
Start: 2025-01-31Target: 24Updated: 2025-02-03